mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.003 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.003 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.004 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.005 |